The top 100 biotech investors; FDA vaccine meeting canceled; Can Bill Anderson save Bayer?; and more

Good morning and rabbit rabbit as we begin the month of March. It was another busy week in the world of biopharma so let’s jump straight into the headlines. John Carroll examined the last year ...